CUTANEOUS VASCULITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammatory and destructive joint damage and extra-articular manifestations involving various organs and systems in the pathological process. One of systemic manifestations of RA is cutaneous rheumatoid vasculitis (RV). Fact...

Full description

Saved in:
Bibliographic Details
Main Authors: David Vladimirovi Bestaev, D E Karateev
Format: Article
Language:Russian
Published: IMA PRESS LLC 2014-03-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1688
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849400074658906112
author David Vladimirovi Bestaev
D E Karateev
author_facet David Vladimirovi Bestaev
D E Karateev
author_sort David Vladimirovi Bestaev
collection DOAJ
description Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammatory and destructive joint damage and extra-articular manifestations involving various organs and systems in the pathological process. One of systemic manifestations of RA is cutaneous rheumatoid vasculitis (RV). Factors predisposing to the development of RV in RA patients include male gender, high titers of rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP) antibodies, antineutrophil cytoplasmic antibodies, and presence of other extra-articular manifestations. RV may develop due to immune complex deposition on the vascular walls. RV activity correlates with high level of RF, anti-CCP and anti-nuclear antibodies. The typical signs of RV include peripheral gangrene, mononeuritis multiplex, as well as scleritis, pericarditis and lung damage. However, skin lesions, such as periungual infarction (digital arteritis), capillaritis, livedo reticularis, and chronic leg ulcers, are more common signs. Development of RV worsens the prognosis of the disease. The 5-year survival rate of RV patients was 28–40% until the principle of early administration of basic anti-inflammatory drugs was implemented. RV is not an independent disease; in most cases, RV alone does not impose a threat to a patient and requires no treatment. Special treatment of cutaneous vasculitis is required in case of venous ulcers only. The article discusses the pathogenesis issues and strategies of RV treatment in RA patients.
format Article
id doaj-art-9b8de0e11cf0487bb4d2d9fc4f97aba3
institution Kabale University
issn 1995-4484
1995-4492
language Russian
publishDate 2014-03-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-9b8de0e11cf0487bb4d2d9fc4f97aba32025-08-20T03:38:11ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922014-03-01521919810.14412/1995-4484-2014-91-981625CUTANEOUS VASCULITIS IN PATIENTS WITH RHEUMATOID ARTHRITISDavid Vladimirovi Bestaev0D E Karateev1V.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaV.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaRheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammatory and destructive joint damage and extra-articular manifestations involving various organs and systems in the pathological process. One of systemic manifestations of RA is cutaneous rheumatoid vasculitis (RV). Factors predisposing to the development of RV in RA patients include male gender, high titers of rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP) antibodies, antineutrophil cytoplasmic antibodies, and presence of other extra-articular manifestations. RV may develop due to immune complex deposition on the vascular walls. RV activity correlates with high level of RF, anti-CCP and anti-nuclear antibodies. The typical signs of RV include peripheral gangrene, mononeuritis multiplex, as well as scleritis, pericarditis and lung damage. However, skin lesions, such as periungual infarction (digital arteritis), capillaritis, livedo reticularis, and chronic leg ulcers, are more common signs. Development of RV worsens the prognosis of the disease. The 5-year survival rate of RV patients was 28–40% until the principle of early administration of basic anti-inflammatory drugs was implemented. RV is not an independent disease; in most cases, RV alone does not impose a threat to a patient and requires no treatment. Special treatment of cutaneous vasculitis is required in case of venous ulcers only. The article discusses the pathogenesis issues and strategies of RV treatment in RA patients.https://rsp.mediar-press.net/rsp/article/view/1688rheumatoid arthritisrheumatoid vasculitistreatment of trophic ulcers
spellingShingle David Vladimirovi Bestaev
D E Karateev
CUTANEOUS VASCULITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
Научно-практическая ревматология
rheumatoid arthritis
rheumatoid vasculitis
treatment of trophic ulcers
title CUTANEOUS VASCULITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
title_full CUTANEOUS VASCULITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
title_fullStr CUTANEOUS VASCULITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
title_full_unstemmed CUTANEOUS VASCULITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
title_short CUTANEOUS VASCULITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
title_sort cutaneous vasculitis in patients with rheumatoid arthritis
topic rheumatoid arthritis
rheumatoid vasculitis
treatment of trophic ulcers
url https://rsp.mediar-press.net/rsp/article/view/1688
work_keys_str_mv AT davidvladimirovibestaev cutaneousvasculitisinpatientswithrheumatoidarthritis
AT dekarateev cutaneousvasculitisinpatientswithrheumatoidarthritis